Silvassa expansion completed early; US exports planned from December

Capex & Operations View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.5%Reaction day

₹72.23

prior close

₹72.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.3%-2.2% vs market

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.2

10m

-2.9

15m

-1.8

30m

-2.0

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-4.5-2.3-2.2

Next day

-3.4-1.9-1.5

-0.3-0.2-0.1

+3.0-0.2+3.2

+2.5+0.5+2.0

-0.8pendingpending

———

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company says its Silvassa manufacturing expansion is complete ahead of schedule. More than 200 surgical, medical-care and hygiene products have US FDA registration, with US exports planned from December 2026. It also plans to assess South American opportunities, subject to regulatory approvals.

Likely market impact

New capacity and US registration improve export readiness and may support growth, but sales will depend on approvals, partners and market demand.